An exploratory study to evaluate biomarkers of prospective multicenter observational study of atezolizumab in patients with locally advanced or metastatic non-small cell lung cancer :J-TAI
Not Applicable
- Conditions
- on-small cell lung cancer
- Registration Number
- JPRN-UMIN000035567
- Lead Sponsor
- Medical Affairs, CHUGAI PHARMACEUTICAL CO., LTD.
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 250
Inclusion Criteria
Not provided
Exclusion Criteria
NONE
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method To evaluate the correlation of values of protein expressions, concentrations of atezolizumab and molecular and functional profiling of T-cell differentiation in peripheral blood with efficacy and safety
- Secondary Outcome Measures
Name Time Method